Injuries

Classification of Tissue Injury in Infections

• Pathological tissue injury resulting from infectious processes is systematically categorized into two distinct mechanistic groups:

  • Immune-Mediated Injuries: Host tissue destruction caused directly by an excessive or misdirected host immune response rather than by microbial cytotoxicity alone.

  • Cytokine Storm-Driven Injury: Systemic, extensive hyperinflammation (e.g., Acute Respiratory Distress Syndrome [ARDS]).

  • Hypersensitivity-Driven Injury: Immune mechanisms classified according to the Coombs and Gell types (Types I, II, III, and IV).

  • Necrosis (Morphological Patterns of Tissue Death): Irreversible cell and tissue injury culminating in distinct macro- and microscopic patterns:

  • Coagulative necrosis

  • Liquefactive necrosis

  • Caseous necrosis

  • Fibrinoid necrosis

  • Gangrenous necrosis

  • Fat necrosis

Cytokine Storm-Driven Injury: Acute Respiratory Distress Syndrome (ARDS)

• Definition and Overview:

  • Acute Respiratory Distress Syndrome (ARDS) is a life-threatening form of widespread, diffuse inflammatory lung injury that leads to increased pulmonary vascular permeability, alveolar flooding, and severe hypoxemia.

  • Etiologies are divided into:

  • Direct lung injury: Severe microbial pneumonia (bacterial or viral).

  • Indirect lung injury: Systemic inflammation secondary to sepsis, extensive physical trauma, or severe burns.

• Clinical Timing and Diagnostic Thresholds:

  • ARDS is strictly an acute condition.

  • Typical clinical onset occurs within $24\text{ to }48\text{ hours}$ following the initial inciting illness or injury.

  • Delayed onset may occur up to $4\text{ to }5\text{ days}$ in a subset of patients.

  • Diagnostic cutoff: If acute respiratory failure manifests more than $7\text{ days}$ after the inciting insult, it is generally excluded from classification as ARDS.

• Incidence:

  • Direct pneumonia etiology: Occurs in approximately $1\text{ in }50$ hospitalized pneumonia patients.

  • Sepsis etiology: Incidence increases substantially to $1\text{ in }3$ septic patients.

• Pathophysiology of the Cytokine Storm:

  • In sepsis (commonly initiated by Gram-negative bacteria), microbial endotoxin (lipopolysaccharide [LPS]) is shed into the circulation.

  • Endotoxin binds pattern recognition receptors on host immune cells, extensively activating macrophages, monocytes, and dendritic cells throughout the vasculature and tissues.

  • Activated cells release an uncontrolled surge of pro-inflammatory cytokines into the systemic circulation:

  • Tumor Necrosis Factor-alpha ($TNF\text{-}\alpha$)

  • Interleukin-1 beta ($IL\text{-}1\beta$)

  • Interleukin-6 ($IL\text{-}6$)

  • When ARDS develops secondary to viral pneumonia (such as severe COVID-19), Interferon-gamma ($IFN\text{-}\gamma$) is concurrently released in substantial titers.

  • This self-amplifying cascade of circulating pro-inflammatory mediators constitutes a cytokine storm, leading to hyperinflammation syndrome, systemic endothelial dysfunction, multi-organ failure, and death.

• Mechanisms of Alveolar Damage and Remodeling:

  • Endothelial Injury: Circulating cytokines act upon pulmonary microvascular endothelial cells, promoting gap formation between endothelial cells and drastically increasing vascular permeability.

  • Epithelial Destruction: Chemotactic gradients (mediated by $IL\text{-}8$, platelet-activating factor [PAF], leukotrienes, and macrophage migration inhibitory factor [MIF]) recruit mass neutrophil infiltrates across the interstitium into the alveoli. Neutrophil degranulation releases oxidants and proteases, killing alveolar type I and type II epithelial cells.

  • Exudation and Surfactant Inactivation: Protein-rich edema fluid, erythrocytes, cellular debris, and fibrin extravasate into the alveolar space, forming dense, waxy hyaline membranes along denuded basement membranes. Surfactant produced by type II pneumocytes is inactivated, leading to widespread microatelectasis and alveolar collapse.

  • Late-Stage Fibrosis: If inflammation remains unresolved, fibroblast proliferation and excessive collagen deposition transform the exudative damage into irreversible intra-alveolar and interstitial fibrosis after $3\text{ weeks}$.

  • Radiographic Findings: Chest radiography or computed tomography (CT) reveals characteristic bilateral, diffuse alveolar opacities ("white-out").

Hypersensitivity-Driven Tissue Injury: Classification and Mechanics

• Type I Hypersensitivity (Immediate / IgE-Mediated):

  • Mechanism: Exogenous allergen cross-links antigen-specific $IgE$ antibodies bound to high-affinity $Fc\epsilon RI$ receptors on mast cells and basophils, triggering immediate degranulation of vasoactive amines (histamine) and synthesis of lipid mediators.

  • Antigens: Exogenous allergens including pollen, molds, dust mites, therapeutic drugs, and food proteins.

  • Antibody: $IgE$.

  • Representative Conditions: Bronchial asthma, urticaria, allergic rhinitis, and systemic anaphylaxis.

• Type II Hypersensitivity (Antibody-Mediated Cytotoxic / Non-Cytotoxic):

  • Mechanism: Antibodies bind directly to fixed cell surface or extracellular matrix antigens, initiating complement-mediated lysis, antibody-dependent cellular cytotoxicity (ADCC), or cellular functional disruption.

  • Antigens: Cell surface or fixed tissue-bound antigens.

  • Antibodies: $IgG$ and $IgM$.

  • Representative Conditions: Autoimmune hemolytic anemia, Goodpasture syndrome, Myasthenia gravis, Acute Rheumatic Fever (ARF), and certain parasitic infections.

• Type III Hypersensitivity (Immune Complex-Mediated):

  • Mechanism: Soluble circulating antigen-antibody complexes form in antigen excess, deposit along basement membranes of blood vessels and filtering membranes, fix complement ($C3a$, $C5a$), and induce neutrophilic leukocytoclastic inflammation.

  • Antigens: Soluble exogenous or endogenous antigens.

  • Antibodies: $IgG$, $IgM$, and $IgA$.

  • Representative Conditions: Systemic lupus erythematosus (SLE), rheumatoid arthritis, Post-Streptococcal Glomerulonephritis (PSGN), and post-hepatitis glomerulonephritis/vasculitis.

• Type IV Hypersensitivity (Cell-Mediated / Delayed-Type Hypersensitivity [DTH]):

  • Mechanism: Primed T lymphocytes ($CD4^+$ Th1 and Th17, and $CD8^+$ cytotoxic T cells) recognize processed peptide antigens presented on major histocompatibility complex (MHC) molecules, secreting cytokines ($IFN\text{-}\gamma$) that activate macrophages, leading to chronic granulomatous inflammation or direct cellular cytotoxicity. Typically manifests $24\text{ to }72\text{ hours}$ post-exposure.

  • Antigens: Cell- or tissue-bound intracellular antigens.

  • Antibodies: None (strictly cell-mediated).

  • Representative Conditions: Allergic contact dermatitis, lepromatous/tuberculoid leprosy, graft-versus-host disease (GVHD), and pulmonary tuberculosis granuloma formation.

Type II Hypersensitivity: Acute Rheumatic Fever (ARF) and Rheumatic Heart Disease

• Definition and Etiology:

  • Acute Rheumatic Fever (ARF) is a delayed, immune-mediated, non-suppurative inflammatory multisystem disease.

  • It develops exclusively following an untreated upper respiratory pharyngeal infection caused by Group A Streptococcus (GAS; Streptococcus pyogenes).

  • Latency period: Clinical onset typically occurs $2\text{ to }4\text{ weeks}$ after acute GAS pharyngitis.

• Pathophysiology and Molecular Mimicry:

  • Virulence M proteins located on the outer cell wall of Streptococcus pyogenes exhibit structural homology to endogenous human alpha-helical coiled-coil structural proteins.

  • Host humoral and cellular responses against streptococcal antigens cross-react with self-tissues:

  • Streptococcal M protein cross-reacts with cardiac myosin, tropomyosin, and laminin.

  • Group A carbohydrate antigens (such as N-acetyl-beta-D-glucosamine [NABG] and rhamnose) cross-react with valve endothelial cells.

  • Antineuronal autoantibodies target dopamine $D_1$ and $D_2$ receptors, tubulin, and lysogangliosides in the central nervous system.

  • Cross-reactive autoantibodies bind to keratin, vimentin, and collagen IV in dermal and synovial connective tissues.

  • Endothelial activation via anti-streptococcal M protein antibodies upregulates adhesion molecules (vascular cell adhesion molecule-1 [VCAM-1], intercellular adhesion molecule-1 [ICAM-1], very late antigen-1 [VLA-1], and lymphocyte function-associated antigen-1 [LFA-1]), promoting the extravasation and transmigration of autoreactive $CD4^+$ T cells into cardiac tissues, culminating in pancarditis.

• Diagnostic Jones Criteria:

  • Diagnosis of an initial episode of ARF requires evidence of a preceding GAS infection plus either 2 Major criteria OR 1 Major + 2 Minor criteria.

  • Evidence of Preceding Infection: Elevated or rising titer of antistreptolysin O (ASOT), elevated anti-DNase B titer, or positive throat culture/rapid antigen detection test for GAS.

  • Major Clinical Manifestations:

  • Carditis (Pancarditis): Observed in $50\%\text{--}70\%$ of cases. Involves the pericardium, myocardium, and endocardium/valves (detectable clinically by murmurs or via Doppler echocardiography).

  • Polyarthritis: Observed in $45\%\text{--}65\%$ of cases. Characterized by migratory, asymmetrical inflammation of large joints (knees, ankles, elbows, wrists). Synovial pathology involves immune complexes binding to the synovial membrane and articular cartilage collagen, recruiting secondary inflammatory cells.

  • Sydenham's Chorea (St. Vitus Dance): Observed in $20\%\text{--}30\%$ of cases. Neurological disorder characterized by rapid, purposeless, irregular, involuntary choreiform movements, muscular weakness, and neurobehavioral changes, resulting from cross-reactive antineuronal antibodies targeting the basal ganglia.

  • Erythema Marginatum: Observed in $1\%\text{--}8\%$ of cases. A distinctive, non-pruritic, pink or erythematous truncal rash with serpiginous, spreading erythematous margins and central clearing (ring-like appearance). It spares the face and hands, is evanescent (shifting shape within minutes to hours), and darkens transiently upon application of heat.

  • Subcutaneous Nodules: Observed in $1\%\text{--}8\%$ of cases. Firm, painless, mobile nodules situated over bony prominences or tendon sheaths, particularly over the metacarpophalangeal (MCP) joints, wrists, elbows, knees, and occiput.

• Minor Clinical Manifestations:

  • Fever: Documented in $60\%\text{--}70\%$ of patients.

  • Elevated Acute-Phase Reactants: Elevated erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), observed in $50\%\text{--}91\%$ of patients.

  • Electrocardiographic Changes: Prolonged P-R interval on ECG or varying degrees of atrioventricular (AV) block, present in $20\%\text{--}25\%$ of cases.

  • Arthralgia: Polyarthralgia, monoarthralgia, or aseptic monoarthritis, present in $10\%\text{--}20\%$ of cases (cannot be counted if polyarthritis is used as a major criterion).

  • Histopathology and Chronic Cardiac Sequelae:

• Aschoff Bodies: Pathognomonic focal interstitial inflammatory myocardial lesions comprising T lymphocytes, scattered plasma cells, and specialized macrophages.

• Aschoff Giant Cells: Large multinucleated cells formed by the coalescence and fusion of activated macrophages or modified myocytes.

• Anitschkow Cells: Specialized, activated histiocytic macrophages characterized by abundant amphophilic cytoplasm and distinctive nuclear chromatin patterns:

  • On longitudinal section: The chromatin condenses into a central, wavy ribbon with delicate radiating projections, producing a caterpillar-like nucleus.

  • On cross-section: The central chromatin condensation surrounded by a clear halo produces an owl-eye appearance.

• Rheumatic Heart Disease (RHD): Over months to years, active exudative valvular inflammation subsides into progressive dense fibrous scarring. Permanent pathological consequences include:

  • Severe fibrous thickening and fusion of mitral valve leaflets, creating a rigid "fish-mouth" or "buttonhole" stenotic valve (mitral stenosis).

  • Shortening, thickening, and fusion of chordae tendineae.

  • Secondary eccentric and concentric left ventricular hypertrophy driven by altered intracardiac hemodynamics.

Type III Hypersensitivity: Post-Streptococcal Glomerulonephritis (PSGN)

• Etiology and Latency Intervals:

  • Post-Streptococcal Glomerulonephritis is an immune complex-mediated inflammatory disease of the renal glomeruli triggered by nephritogenic strains of Group A Streptococcus.

  • Pharyngeal portal: Follows streptococcal pharyngitis with a latency of $1\text{ to }2\text{ weeks}$ (nephritogenic M-protein serotypes: $M1$, $M2$, $M4$, $M12$, and $M25$).

  • Cutaneous portal: Follows superficial streptococcal pyoderma or impetigo with a longer latency of $3\text{ to }6\text{ weeks}$ (nephritogenic M-protein serotypes: $M2$, $M42$, $M49$, $M55$, $M57$, $M60$, and $M61$).

• Pathogenesis of Molecular Mimicry:

  • Nephritogenic streptococci express outer surface proteins (such as streptococcal pyrogenic exotoxin B [SPEB] and nephritis-associated plasmin receptor [NAPlr]) as well as specialized M proteins that share structural configurations with host circulating and structural proteins, notably plasminogen, fibrinogen, and Factor H.

  • Cross-reactive antibodies bind circulating bacterial antigens to form soluble circulating immune complexes, or bind planted streptococcal antigens directly within the glomerular basement membrane.

• Normal Glomerular Architecture:

  • The filtration barrier comprises three functional layers: fenestrated endothelial cells lining the capillary lumen, the glomerular basement membrane (GBM), and visceral epithelial cells (podocytes) with interdigitating foot processes separated by filtration slit diaphragms.

  • The capillary loops are supported centrally by mesangial cells suspended within an extracellular mesangial matrix, bounded externally by Bowman's capsule, parietal epithelial cells, and the urinary space draining into the proximal convoluted tubule.

• Diagnostic and Pathological Hallmarks:

  • Light Microscopy: Diffuse, global endocapillary hypercellularity involving all glomeruli, driven by proliferation of endothelial and mesangial cells alongside substantial infiltration of neutrophils and monocytes, completely occluding capillary lumina.

  • Immunofluorescence Microscopy: Coarse, granular deposition of $IgG$ and complement fraction $C3$ along the glomerular basement membranes and within mesangial regions in a classic "starry sky" or "lumpy-bumpy" pattern.

  • Electron Microscopy: Pathognomonic large, discrete, electron-dense subepithelial "humps" located in the space between the outer surface of the lamina densa of the GBM and the overlying podocytes.

  • Classic Clinical Triad (Nephritic Syndrome):

  1. Hematuria: Grossly smoky, tea-colored, or cola-colored urine with dysmorphic red blood cells and RBC casts.

  2. Edema: Typically starts as dependent periorbital and facial puffiness upon waking, later progressing to generalized peripheral edema due to sodium and water retention.

  3. Hypertension: Mild to moderate elevated arterial pressure secondary to intravascular fluid expansion and reduced glomerular filtration rate.

Overview of Necrosis in Infectious Diseases

• General Distribution of Necrosis Patterns:

  • Coagulative necrosis: The most prevalent pattern of necrosis across general human pathology, predominantly driven by vascular ischemia.

  • Liquefactive necrosis: The most frequent and hallmark pattern of necrosis occurring specifically within active bacterial infections.

  • Caseous necrosis: The unique hallmark of mycobacterial infections (tuberculosis) and specific fungal granulomas.

  • Gangrenous necrosis: Typical consequence of severe vascular compromise, infected ischemic limbs, and clostridial soft-tissue infections.

  • Fibrinoid necrosis: Characteristic of immune complex-mediated necrotizing vasculitides associated with chronic microbial infections.

  • Fat necrosis: Result of enzymatic adipose tissue autodigestion secondary to pancreatic pathology or infection.

• Infection Prevalences and Rules:

  • Liquefactive necrosis is the primary driver of purulent exudate (pus generation) and focal abscess formation in bacterial infections.

  • Coagulative necrosis is not primarily initiated by microbial cytotoxicity; it occurs during infection strictly when the infectious agent induces secondary tissue ischemia.

Coagulative Necrosis

• Fundamental Pathological Mechanism:

  • The primary driver of coagulative necrosis is ischemia (cessation of arterial perfusion or profound microvascular thrombosis).

  • Ischemia leads to severe cellular hypoxia, intracellular acidosis, and rapid protein denaturation.

  • Denaturation inactivates both structural proteins and enzymatic machinery (including the cell's own lysosomal and autolytic enzymes), preventing immediate enzymatic lysis of the dead tissue.

• Morphological and Structural Characteristics:

  • Preservation of Tissue Architecture: Structural framework and cellular boundaries are preserved for days following cell death; this architectural retention represents the distinguishing hallmark of coagulative necrosis.

  • Microscopic Appearance ("Ghost Cells"): Affected cells retain their eosinophilic outlines and structural boundaries, but display total loss of nuclear detail through karyolysis, pyknosis, or karyorrhexis.

  • Macroscopic Appearance: Affected parenchyma appears pale, firm, dehydrated, and circumscribed.

• Mechanisms Whereby Infections Induce Ischemia:

  • 1. Microvascular Thrombosis: Direct microbial invasion of vascular endothelia or localized hypercoagulability leading to terminal microvessel occlusion and infarction (e.g., Fusobacterium necrophorum causing suppurative thrombophlebitis and liver abscesses in Lemierre's-like pathologies).

  • 2. Disseminated Intravascular Coagulation (DIC): Severe systemic bacterial sepsis and fulminant meningococcemia (Neisseria meningitidis) triggering systemic consumptive microvascular fibrin deposition, tissue hypoperfusion, and widespread ischemic coagulative necrosis.

  • 3. Infectious Vasculitis with Thromboembolism: Vegetations from infective endocarditis breaking off to form septic emboli, mechanically occluding downstream arterioles and triggering ischemic infarction.

Liquefactive Necrosis

• Pathological Mechanism:

  • The defining mechanism is the rapid enzymatic digestion of cellular architecture by powerful hydrolytic lysosomal enzymes (proteases, lipases, nucleases).

  • These enzymes originate from the lysosomes of recruited host polymorphonuclear leukocytes (neutrophils) as well as the autolytic release from dying host and microbial cells.

• Structural and Clinical Features:

  • Loss of Tissue Architecture: Unlike coagulative necrosis, the structural framework of the tissue is completely dissolved and liquefied, converting into an amorphous, fluid-filled mass.

  • Lesion Characteristics: Results in a localized, circumscribed, pus-filled cavity (abscess) or a fluid-filled cystic cavity containing thick purulent material composed of necrotic cellular debris, dead neutrophils, and proteinaceous fluid.

  • Predilection Sites:

  • Characteristic of focal bacterial infections (e.g., Staphylococcus aureus or Streptococcus species causing acute abscesses in lung, skin, or liver).

  • Characteristic of localized fungal infections.

  • The primary pattern of ischemic necrosis within the Central Nervous System (hypoxic brain infarction) due to the brain's rich content of hydrolytic enzymes and lack of supportive fibrous stroma.

Caseous Necrosis

• Etiology and Pathological Mechanism:

  • Caseous necrosis is a specialized form of cell death driven by persistent, antigen-rich chronic granulomatous inflammation (Type IV delayed hypersensitivity).

  • Most characteristically provoked by Mycobacterium tuberculosis, as well as deep systemic fungal pathogens (such as Histoplasma capsulatum, Coccidioides immitis, and Blastomyces dermatitidis).

• Morphological Features:

  • Macroscopic (Gross) Pathology: Tissue appears soft, friable, granular, and yellowish-white, resembling clumpy cheese ("caseous"). A classic manifestation is the subpleural caseous focus (Ghon focus) in primary pulmonary tuberculosis.

  • Microscopic Pathology: The architecture of the tissue is completely obliterated. The necrotic core consists of amorphous, structureless, granular, eosinophilic cellular debris devoid of recognizable cell ghosts. This necrotic center is encircled by a chronic granuloma comprising palisading epithelioid histiocytes (activated macrophages), Langhans multinucleated giant cells (horseshoe-arranged nuclei), a dense peripheral rim of $CD4^+$ T lymphocytes, and outer fibrous connective tissue encapsulation.

  • Diagnostic tissue biopsy specimens are routinely harvested from enlarged supraclavicular lymph nodes or apical lung wedges to definitively demonstrate caseating granulomas.

Fibrinoid Necrosis

• Pathological Mechanism:

  • Fibrinoid necrosis occurs when circulating antigen-antibody immune complexes deposit within the tunica media and intima of arterial and arteriolar walls.

  • Immune complex entrapment activates the classical complement pathway, triggering acute inflammation that damages the vascular basement membrane and increases endothelial permeability.

  • Plasma proteins, notably fibrinogen, leak out of the lumen into the vessel wall, where they polymerize into fibrin and mix with degraded cellular proteins and immune complexes.

• Microscopic and Clinical Features:

  • Microscopic Appearance: The damaged blood vessel wall loses its distinct structural layers and appears expanded by a bright pink, homogenous, smudgy, amorphous, intensely eosinophilic ring ("fibrinoid" appearance). The lesion displays transmural infiltration of disintegrating, karyorrhectic neutrophils (leukocytoclasia).

  • Infectious Manifestations: Chronic systemic viral infections, primarily Hepatitis B virus (HBV) and Hepatitis C virus (HCV), trigger necrotizing vasculitis as a major extrahepatic manifestation.

  • Mixed Cryoglobulinemia Syndrome: In chronic HCV, abnormal cold-precipitable immunoglobulins ($IgG\text{-}IgM\kappa$ cryoprecipitates that precipitate below $37^\circ\text{C}$ and dissolve upon rewarming, observed after $7\text{ days}$ at $+4^\circ\text{C}$) deposit in small vessels. This triggers leukocytoclastic cryoglobulinemic vasculitis, presenting with lower-extremity palpable purpura, extensive dermal necrotic ulcers, arthralgias, and glomerulonephritis.

Gangrenous Necrosis

• Definition and Overview:

  • Gangrene is a clinical term applied to extensive, progressive tissue death affecting an extremity or internal visceral organ, usually initiated by critical vascular ischemia.

  • Classified into three pathological entities: Dry Gangrene, Wet Gangrene, and Gas Gangrene.

• Dry Gangrene vs. Wet Gangrene:

  • Dominant Necrotic Mechanism:

  • Dry Gangrene: Predominantly consists of pure coagulative necrosis.

  • Wet Gangrene: Predominantly consists of liquefactive necrosis superimposed upon coagulative necrosis as a consequence of secondary bacterial invasion.

  • Primary Etiologies:

  • Dry Gangrene: Pure arterial vascular occlusion without significant venous outflow obstruction (e.g., peripheral artery disease, severe atherosclerosis, thromboangiitis obliterans).

  • Wet Gangrene: Venous blockage and vascular congestion (e.g., strangulated hernia with bowel incarceration, intestinal intussusception, or mesenteric volvulus), or secondary bacterial infection of an ischemic diabetic extremity.

  • Anatomical Sites:

  • Dry Gangrene: Distal portions of limbs (toes, feet, lower legs, fingers).

  • Wet Gangrene: Moist internal viscera (small and large bowel, lungs) as well as soft tissues of contaminated limbs.

  • Line of Demarcation:

  • Dry Gangrene: Clear-cut, distinct border between viable healthy tissue and black necrotic tissue.

  • Wet Gangrene: Ill-defined, indistinct border without a clear demarcation line; erythema and swelling extend into viable tissue.

  • Gross Characteristics:

  • Dry Gangrene: Dry, shrunken, mummified, wrinkled, and black/dark brown.

  • Wet Gangrene: Swollen, edematous, soft, foul-smelling, and discolored with bleb and bullae formation.

  • Rate of Progression and Prognosis:

  • Dry Gangrene: Spread is slow; systemic toxicity is limited; prognosis is fair.

  • Wet Gangrene: Spread is rapid and fulminant; bacteria proliferate and release toxins into circulation, producing septicemia; prognosis is extremely poor, representing an absolute surgical emergency.

• Gas Gangrene (Clostridial Myonecrosis):

  • Severe, rapidly fatal invasive bacterial infection of muscle and subcutaneous tissues.

  • Etiological Agent: Clostridium perfringens (an anaerobic, spore-forming, Gram-positive bacillus).

  • Pathogenesis: Bacteria enter deep, devitalized wounds with low oxidation-reduction potential. C. perfringens produces potent exotoxins, notably alpha toxin (a phospholipase C / lecithinase), which degrades cell membranes, lyses erythrocytes, destroys endothelial cells, and produces profound ischemic myonecrosis.

  • Manifestations: Fermentation of tissue carbohydrates produces insoluble subcutaneous gas pockets, manifesting clinically as palpable crepitus, hemorrhagic dark bullae, extensive necrotizing fasciitis, profound hemolytic anemia, systemic shock, and rapid death.

Fat Necrosis

• Pathological Mechanism:

  • Fat necrosis is non-viable adipose tissue death mediated by the pathological leakage and activation of pancreatic lipases.

  • Activated lipases escape from damaged pancreatic acinar cells or ductules into the surrounding peripancreatic, mesentery, or peritoneal fatty tissue.

  • Lipases hydrolyze intracellular neutral triglycerides into free fatty acids and glycerol.

  • The liberated free fatty acids bind extracellular ionized calcium ($Ca^{2+}$), undergoing a chemical reaction termed saponification to produce insoluble chalky-white, macroscopic calcium soaps.

• Microscopic and Clinical Features:

  • Microscopic Appearance: Necrotic adipocytes lose their peripheral nuclei while retaining shadowy cell outlines ("ghost" fat cells). The cytoplasm contains cloudy, amorphous, granular basophilic (blue-staining) calcium deposits along the interlobular septa and intracellular spaces.

  • Clinical Etiologies: Most frequently encountered in acute viral pancreatitis (such as mumps, Coxsackievirus, or viral hepatitis) or acute bacterial/obstructive pancreatitis, as well as blunt physical trauma to the adipose tissue of the breast.